UK group explores sale of future income streams from some of its existing medicines to help thwart a renewed takeover attempt by rival Pfizer
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com